Boehringer Pays $650M To Settle Pradaxa MDL
Boehringer Ingelheim International GmbH has agreed to pay roughly $650 million to settle claims in multidistrict litigation that its blood thinner Pradaxa caused serious injuries including severe bleeding, the German drugmaker...To view the full article, register now.
Already a subscriber? Click here to view full article